• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RMT311415
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 07/20/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The review of the manufacturing records verified that the lots involved in this event met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), complications associated with the use of the gore® excluder® aaa endoprosthesis may include but are not limited to: endoleaks.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2013, this patient underwent endovascular treatment for an abdominal aortic aneurysm (aaa) measuring 80 mm in diameter and was treated with gore® excluder® aaa endoprostheses.On (b)(6) 2017, ultrasound examination revealed an aneurysm diameter of 88 mm.On (b)(6) 2017, ultrasound examination identified an aneurysm diameter of 90 mm.On (b)(6) 2018, computed tomography angiography imaging confirmed an aneurysm diameter of 94 mm.On (b)(6) 2018, an additional graft was implanted during an endovascular procedure to treat a persisting type 1a or type ii endoleak.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7941233
Report Number2017233-2018-00593
Device Sequence Number11100943
Product Code MIH
UDI-Device Identifier00733132610754
UDI-Public00733132610754
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Reporter Type Manufacturer
Report Source study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/31/2014
Device Catalogue NumberRMT311415
Device Lot Number9752354
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date10/06/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age78 YR
Patient Weight103
-
-